Repeat treatment for recurrent hepatocellular carcinoma: is it validated? (Q44359689)

2 December 2017

Repeat treatment for recurrent hepatocellular carcinoma: is it validated? (English)

1 reference

recurrent hepatocellular carcinoma

2 December 2017

1 reference

8

Norihiro Kokudo

1 reference

2 December 2017

Yoji Kishi

1

1 reference

2 December 2017

Akio Saiura

2

1 reference

2 December 2017

Junji Yamamoto

3

1 reference

2 December 2017

Rintaro Koga

4

1 reference

2 December 2017

Makoto Seki

5

1 reference

2 December 2017

Ryo Morimura

6

1 reference

2 December 2017

Ryuji Yoshioka

7

1 reference

2 December 2017

Toshiharu Yamaguchi

9

1 reference

2 December 2017

language of work or name

English

0 references

publication date

17 August 2011

1 reference

Langenbeck's Archives of Surgery

2 December 2017

1 reference

2 December 2017

396

1 reference

2 December 2017

7

1 reference

2 December 2017

1093-1100

1 reference

https://scigraph.springernature.com/pub.10.1007/s00423-011-0837-0

2 December 2017

0 references

cites work

Repeat liver resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Criteria for safe hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Prognostic Factors and Optimal Treatment Strategy for Intrahepatic Nodular Recurrence After Curative Resection of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-011-0837-0

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence

1 reference

12 December 2020

Repeat hepatectomy for recurrent hepatocellular carcinoma

1 reference

12 December 2020

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

12 December 2020

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response

1 reference

12 December 2020

Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study

1 reference

12 December 2020

Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus

1 reference

12 December 2020

Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer

1 reference

12 December 2020

Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection

1 reference

12 December 2020

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

12 December 2020

Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience

1 reference

12 December 2020

Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome

1 reference

12 December 2020

Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes

1 reference

12 December 2020

Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan

1 reference

12 December 2020

Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: Univariate and multivariate analyses

1 reference

12 December 2020

Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors

1 reference

12 December 2020

Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00423-011-0837-0

Identifiers

DOI

1 reference

2 December 2017

1 reference